NEW YORK (GenomeWeb News) – Millipore said today that it will work with Agilent Technologies to develop chromatin immunoprecipitation kits for the epigenetics research market.
The collaboration will involve teaming Millipore’s knowledge in ChIP kits, reagents, and antibodies with Agilent’s microarray and data analysis solutions, the Billerica, Mass.-based Millipore stated.
The aim is to use these combined technologies to create kits that will improve researchers’ productivity and streamline genetic analysis studies, the companies said.
“We expect to help epigenetics researchers minimize the barriers of entry into chromatin state mapping, readily obtain reproducible genomic profiling data, and overcome the traditional challenges of ChIP assays," said Geoffrey Crouse, VP of Millipore's life science strategic business unit.
Agilent developed its microarray-based ChIP-on-chip technology after its 2005 acquisition of Computational Biology Corporation.